Coya Therapeutics COYA
NASDAQ COYA
$4.23 +0.02 (+0.48%)
As of: Oct 21, 2026 · 11:38 AM EDT

Coya Therapeutics (COYA) Other financing activities (2022)

Updated

Coya Therapeutics (COYA) reported Other financing activities of $997,367 for FY2022.

Analysis

Coya Therapeutics (COYA) Other financing activities (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn
10 Coya Therapeutics 99.46 Mn -69.42 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 -931,982.00
Mar 31, 2022 -65,385.00
API Access

Coya Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=COYA&period=max&api_key=YOUR_API_KEY